| Factor Information | |
|---|---|
| Data ID | 1739 |
| Factor | Laboratories on PCICU admission--PO2 |
| Description | The subjects in the dexmedetomidine group were older, had a higher BSA, had shorter CPB and cross-clamp times, and had lower lactate levels at admission to the PCICU. |
| Biomarker | NA |
| Classification | E11 (physiological factor - physical sign) |
| Association | |
|---|---|
| Application | treatment and prognosis |
| Objective | examine for an association between dexmedetomidine use in the immediate postoperative period and subsequent arrhythmia development after heart surgery |
| p Value | <0.001 |
| Conclusion | The subjects in the dexmedetomidine group were older, had a higher BSA, had shorter CPB and cross-clamp times, and had lower lactate levels at admission to the PCICU. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 25878324 |
| Year | 2015 |
| Title | Association between perioperative dexmedetomidine and arrhythmias after surgery for congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | an ongoing prospective observational study | |
| Region | Nashville, USA | |
| Method | prospective observational study | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | cardiac surgery | |
| Group | DEX(dexmedetomidine) group(Treatment) | CHD group without DEX(Control) |
| Number | 468 | 1125 |
| Age | 784 (175 to 1794) days | 127 (13 to 379) days |
| Gender (Male: Female) | 239:229 | 625:500 |
| Marker Level | 99 (59 to 166) | 74 (44 to 137) |
